As the US Food and Drug Administration and industry cannonballed into June with an explosion of drug development announcements, it was impossible to keep the news brief. So we'll skip the preamble this week and bring you directly to the meat of the action.
It looks like 2019 will be the year the FDA approves the first product with a regenerative medicine advanced therapy...








